Exercise during chemotherapy for ovarian cancer (Echo) : study design features and outcomes of a Cancer Australia and Cancer Council Australia funded randomised, controlled trial
| Data(s) |
2014
|
|---|---|
| Resumo |
Ovarian cancer is the most common cause of gynaecological cancer death, with an overall 5-year relative survival of 43%. Impaired physical wellbeing and overall quality of life (QoL) represent major concerns for women during and following ovarian cancer treatment, predict survival and are amenable to change through interventions. Exercise, now considered an important part of overall management of a number of cancers, improves short-term outcomes (e.g., function, fatigue, QoL) during chemotherapy... |
| Formato |
application/pdf |
| Identificador | |
| Publicador |
Lippincott Williams & Wilkins, Ltd. |
| Relação |
http://eprints.qut.edu.au/81851/2/81851.pdf http://igcs.meetingexpert.net/igcs_300/poster_109083/program.aspx/anchor109083 Hayes, Sandra C., Friedlander, Michael, Obermair, Andreas, Mileshkin, Linda, Janda, Monika, Gordon, Louisa, Barnes, Emma C., Beesley, Vanessa L., Eakin, Elizabeth, Sommeijer, Dirkje, Martyn, John, Stockler, Martin, Gebski, Val, Naumann, Fiona L., Schmitz, Kathryn H., & Webb, Penelope (2014) Exercise during chemotherapy for ovarian cancer (Echo) : study design features and outcomes of a Cancer Australia and Cancer Council Australia funded randomised, controlled trial. In 15th Biennial Meeting of the International Gynecologic Cancer Society, 8-11 November 2014, Melbourne, VIC. |
| Direitos |
Copyright 2014 [please consult the authors] |
| Fonte |
Faculty of Health; Institute of Health and Biomedical Innovation; School of Public Health & Social Work |
| Palavras-Chave | #110000 MEDICAL AND HEALTH SCIENCES #111700 PUBLIC HEALTH AND HEALTH SERVICES #anzsrc Australian and New Zealand Standard Research Class |
| Tipo |
Conference Item |
